NYSE

Stryker Corporation (SYK)

347 Thanks from members

Stryker Corporation (SYK) exhibits resilient market sentiment supported by strong underlying demand in orthopedics and MedSurg, solid Q2 results, and reaffirmed full-year guidance, despite a temporary mid-March cyber disruption that impacted Q1 performance.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →